Hear.com Horizon Go IX vs Signia Pure C&G IX

The Hear.com Horizon Go IX is a premium prescription behind-the-ear hearing aid released in 2024, listed at $6,500. In HearAdvisor's lab testing, it earned an A grade with a SoundScore of 4.4/5, ranking #17 among 36 prescription hearing aids tested. This device demonstrates particular strength in speech clarity. Speech in quiet scored a strong 4.0/5, which is +0.72 points above the category average. Speech in noise performance also exceeded the category average by +0.61 points, though at 2.6/5 the absolute score remains mixed—meaning it handles challenging listening environments better than many competitors but still has room for improvement in demanding situations. The most notable limitation is own-voice comfort, scoring 1.8/5—a low result that falls 0.95 points below the category average. Users sensitive to how their own voice sounds may find this particularly noticeable. Feedback handling is strong in absolute terms at 4.4/5, though it sits slightly below the category average by 0.31 points. Music streaming performance is mixed at 2.7/5, essentially matching the category average. At this price point, the Horizon Go IX faces stiff competition. Same-price alternatives like the Phonak Sphere Infinio (5.0/5) and Oticon Intent (4.85/5) deliver higher overall sound performance. Budget-conscious shoppers might also consider options like the Rexton Reach R-Li T80 at Costco, which achieves a higher score at a lower price. The Horizon Go IX is best suited for those prioritizing speech clarity who can accept the own-voice trade-off and prefer the hear.com service model.

The Signia Pure C&G IX is a premium prescription behind-the-ear hearing aid released in 2023, currently available at $3,298. In HearAdvisor's lab testing, it earned an A grade with a SoundScore of 4.1/5, ranking #20 among 36 prescription hearing aids tested. This device demonstrates consistent strength across multiple performance areas. Speech in quiet scored a solid 4.0/5, sitting 0.65 points above the category average. Speech in noise performance, while above the category average by 0.25 points, remains mixed in absolute terms at 2.2/5—a common challenge across prescription devices. Feedback handling is a standout feature, achieving a perfect 5.0/5 and exceeding the already-high category average. Own-voice comfort scores a solid 3.2/5, running 0.45 points above the category average, which suggests good occlusion management. Music streaming performs solidly at 3.0/5, also above average for the category by 0.36 points. The device supports both iPhone and Android streaming along with hands-free functionality. Professional tuning yields meaningful improvement, with the normalized score increasing from 4.0/5 to 4.5/5. Buyers seeking top-tier performance in this price range should note that competitors like the Phonak Sphere Infinio (5.0/5) and Oticon Intent (4.85/5) scored higher in our testing. The Pure C&G IX may suit those who prioritize reliable feedback control and balanced everyday performance over maximum speech-in-noise capability.